XML 81 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Share-based compensation (Tables)
12 Months Ended
Mar. 31, 2023
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]  
Summary of Stock Option Activity
The following table sets forth the share options activity for the years ended March 31, 2022 and 2023:
 
    
Number of
shares
   
Weighted
average
exercise price
    
Weighted average
remaining
contractual term
    
Aggregate
intrinsic
value
    
Weighted average
fair value
 
          
US$
           
US$
    
US$
 
Outstanding as of March 31, 2021
     5,512,222       3.36        6.32        29,360        3.28  
Exercisable as of March 31, 2021
     —         —          —          —          —    
Granted
     1,282,500       2.86                          2.27  
Exercised
     (1,204,483     1.09                          0.73  
Forfeited
     (358,348     2.86                          3.83  
Outstanding as of March 31, 2022
     5,231,891       2.86        5.25        404        2.36  
Exercisable as of March 31, 2022
     —         —          —          —          —    
Exercised
     (53,488     0.60                          2.26  
Forfeited
     (1,233,050     1.31                          0.86  
Outstanding as of March 31, 2023
     3,945,354       2.58        3.45        124        2.06  
Exercisable as of March 31, 2023
     —         —          —          —          —    
Summary of Options Measured At Fair Value, Valuation Assumptions The significant unobservable inputs adopted in the valuation as of March 31, 2022 and 2023 are as follows:
 
    
As of March 31,
2022
  
As of March 31,
2023
Spot price (US$)
   0.44, 6.93    5.90
Risk-free rate
   1.25%, 2.5%    3.83%
Expected volatility
   57.95%, 48.15%    61.13%
Expected expiry years (in years)
   0.50, 3.56    2.60
Employees and Non Employees [Member]  
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]  
Summary of Options Measured At Fair Value, Valuation Assumptions
    
Year ended March 31, 2022
Expected volatility
  
42.22
% - 
43.71%
Risk-free interest rate
   1.62
% - 
1.86%
Exercise multiple
   2.8/2.2
Expected dividend yield
   0%
Contractual term (in years)
   10